HealthEquity (NASDAQ:HQY) Price Target Raised to $130.00

HealthEquity (NASDAQ:HQY) had its target price upped by BTIG Research from $110.00 to $130.00 in a research note released on Thursday morning,Benzinga reports. BTIG Research currently has a buy rating on the stock.

Other equities analysts have also recently issued research reports about the company. Royal Bank of Canada reiterated an “outperform” rating and set a $92.00 price target on shares of HealthEquity in a report on Wednesday, September 4th. JMP Securities reiterated a “market outperform” rating and set a $105.00 target price on shares of HealthEquity in a research note on Wednesday, September 4th. Deutsche Bank Aktiengesellschaft increased their price target on HealthEquity from $102.00 to $103.00 and gave the company a “buy” rating in a research note on Wednesday, September 4th. Bank of America lifted their price objective on shares of HealthEquity from $100.00 to $120.00 and gave the stock a “buy” rating in a research report on Wednesday, November 13th. Finally, Barrington Research reissued an “outperform” rating and issued a $105.00 price objective on shares of HealthEquity in a research report on Friday, September 20th. One investment analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $107.23.

HealthEquity Trading Up 3.4 %

Shares of HealthEquity stock opened at $98.98 on Thursday. HealthEquity has a 12-month low of $62.10 and a 12-month high of $101.17. The company has a quick ratio of 4.10, a current ratio of 4.10 and a debt-to-equity ratio of 0.51. The business’s 50 day moving average is $85.02 and its 200-day moving average is $81.09. The stock has a market cap of $8.64 billion, a P/E ratio of 82.48, a P/E/G ratio of 1.55 and a beta of 0.52.

HealthEquity (NASDAQ:HQY) last posted its quarterly earnings results on Tuesday, September 3rd. The company reported $0.66 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.50 by $0.16. HealthEquity had a net margin of 9.61% and a return on equity of 9.01%. The firm had revenue of $299.93 million for the quarter, compared to analyst estimates of $284.48 million. Equities research analysts predict that HealthEquity will post 2.27 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other HealthEquity news, Director Frank Corvino sold 1,039 shares of HealthEquity stock in a transaction on Wednesday, November 6th. The stock was sold at an average price of $96.10, for a total value of $99,847.90. Following the completion of the transaction, the director now directly owns 3,784 shares of the company’s stock, valued at $363,642.40. The trade was a 21.54 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Robert W. Selander sold 8,250 shares of the company’s stock in a transaction on Wednesday, October 9th. The shares were sold at an average price of $82.98, for a total value of $684,585.00. Following the sale, the director now owns 54,719 shares of the company’s stock, valued at approximately $4,540,582.62. The trade was a 13.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 10,536 shares of company stock worth $884,517 in the last quarter. 2.20% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On HealthEquity

Several hedge funds have recently bought and sold shares of HQY. International Assets Investment Management LLC acquired a new stake in shares of HealthEquity during the 2nd quarter worth approximately $35,000. Paladin Wealth LLC acquired a new stake in shares of HealthEquity in the 3rd quarter valued at $39,000. GAMMA Investing LLC increased its stake in shares of HealthEquity by 114.8% in the 2nd quarter. GAMMA Investing LLC now owns 595 shares of the company’s stock valued at $51,000 after purchasing an additional 318 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. bought a new position in shares of HealthEquity in the 2nd quarter valued at $73,000. Finally, Quarry LP raised its holdings in shares of HealthEquity by 418.8% during the 3rd quarter. Quarry LP now owns 1,349 shares of the company’s stock worth $110,000 after buying an additional 1,089 shares in the last quarter. 99.55% of the stock is owned by institutional investors.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.